直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

PTAB Did Not Err in Allowing Petitioner to Add Real Party-in-Interest Without Changing Petition’s Filing Date

July 2, 2019

Authored and Edited by Ryan V. McDonnell; Kevin D. Rodkey; Elizabeth D. Ferrill

In Mayne Pharma International Pty. Ltd. v. Merck Sharp & Dohme Corp., No. 2018-1593 (Fed. Cir. June 21, 2019), the Federal Circuit held that the PTAB did not err by allowing Merck to amend its disclosures to identify its parent company as a real party-in-interest without affecting the petition’s filing date.

After Merck filed a petition for IPR challenging Mayne’s patent, Mayne argued, both before and after institution, that Merck’s IPR petition was incomplete and time barred for failing to identify Merck’s parent entity as a real party-in-interest. The PTAB allowed Merck to amend its mandatory notices to include its parent company without affecting the petition’s filing date. In its final written decision, the PTAB rejected Mayne’s time-bar argument as moot and found the challenged claims unpatentable.

On appeal, the Federal Circuit held that the PTAB did not err in finding that the “interests of justice” permitted allowing Merck to amend the identified real parties-in-interest. In reaching this conclusion, the court explained that both Merck and its patent had agreed to be bound by the estoppel effects from the IPR, that the Board was apprised of conflicts relating to Merck and its parent, that Merck did not attempt to conceal its parent’s identity, and that Mayne’s position was not changed by the amendment. The court also referred to the Supreme Court’s Cuozzo decision and other PTAB decisions allowing amendment to find that the PTAB did not err by allowing Merck to add a real party in interest without changing a petition’s filing date.

Tags

jurisdiction, Patent Trial and Appeal Board (PTAB), real parties in interest

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Ryan V. McDonnell
Associate
Washington, DC
+1 202 408 4167
Email
Kevin D. Rodkey
Partner
Atlanta, GA
+1 404 653 6484
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP